Texas seeks businesses to cultivate, validate and administer drugs made from cannabis compounds, which are used to treat seizures in epilepsy patients. Vyripharm Pharmaceuticals is positioning itself to play a key role in that new state health initiative. The Texas Compassionate Use Act, signed into law on June 1, 2015, requires that the state license at … Continue reading Vyripharm wants in on Texas’ medical cannabis initiative